Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
5.76
0.25 (4.54%)
At close: Aug 18, 2025, 3:59 PM
5.85
1.47%
After-hours: Aug 18, 2025, 07:05 PM EDT
4.54% (1D)
| Bid | 4.17 |
| Market Cap | 395.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -128.89M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -2.93 |
| Forward PE | -2.13 |
| Analyst | Buy |
| Ask | 6 |
| Volume | 343,587 |
| Avg. Volume (20D) | 692,562 |
| Open | 5.57 |
| Previous Close | 5.51 |
| Day's Range | 5.51 - 5.77 |
| 52-Week Range | 2.86 - 13.93 |
| Beta | 1.93 |
About OLMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OLMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OLMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 days ago
+16.19%
Olema Pharmaceuticals shares are trading higher. T...
Unlock content with
Pro Subscription
8 months ago
+0.89%
Olema Pharmaceutical shares are trading higher after the company announced a new clinical trial collaboration and supply agreement with Novartis for frontline metastatic breast cancer. Also, the company entered into a private placement of common stock worth $250 million.
